feed,title,long_url,short_url
Benzinga,Iterum Therapeutics plc Increases Previously Announced Bought Deal Public Offering of Ordinary Shares to $40.0 Million,https://www.benzinga.com/pressreleases/21/02/g19481620/iterum-therapeutics-plc-increases-previously-announced-bought-deal-public-offering-of-ordinary-sha,https://j.mp/39Qi8rv
Benzinga,Revolution Medicines Announces Pricing of Upsized $260.9 Million Public Offering of Common Stock,https://www.benzinga.com/pressreleases/21/02/g19481601/revolution-medicines-announces-pricing-of-upsized-260-9-million-public-offering-of-common-stock,https://j.mp/3rpinQb
Benzinga,COVID-19 Impact and Recovery Analysis | Sweeteners Market Procurement Intelligence Report Forecasts Spend Growth of Over USD 18.41 Billion | SpendEdge,https://www.benzinga.com/pressreleases/21/02/b19481600/covid-19-impact-and-recovery-analysis-sweeteners-market-procurement-intelligence-report-forecasts-,https://j.mp/3tpN1ut
